Rapid, Point of Care Diagnostic for Malaria, highly sensitive for P. vivax, with species differentiation
Rapid, Point of Care Diagnostic for Malaria, highly sensitive for P. vivax, with species differentiation
批准号:
10082346
负责人:
PETER GALEN
金额:
$84.04万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
已结题
起止时间:
2020-08-06 至 2022-07-31
关键词:
AffectAlgorithmsBirefringenceBloodCessation of lifeClinicalClinical DataClinical ResearchContractsDetectionDevicesDiagnosisDiagnosticDiffuseDiseaseDisease ProgressionElectronicsFundingGoalsHemoglobinHumanIncidenceInfectionIronLiverMalariaMetastatic Neoplasm to the LiverMicroscopyNoiseOpticsOutcomeParasitesPatientsPharmaceutical PreparationsPhasePlasmodium falciparumPlasmodium vivaxPlasticsPrevalencePublished CommentReactionReaderRecurrent diseaseRegimenRunningSensitivity and SpecificityShapesSignal TransductionSmall Business Innovation Research GrantSystemTechnologyTestingTimeTreatment ProtocolsUnited States National Institutes of HealthValidationVirulentWorkhemozoinimprovedmagnetic fieldmalaria infectionmalaria transmissionpoint of carepoint-of-care diagnosticsportabilitysignal processingtime use
中文摘要
项目概要/摘要
虽然在降低疟疾流行率和死亡率方面取得了重大进展,但疟疾
消除仍然是一个极其困难的目标。恶性疟原虫和间日疟原虫
寄生虫占所有人类疟疾感染的~95%。恶性疟原虫的毒性更强,
不良临床结局的发生率较高,但间日疟原虫更普遍,
分布广泛,往往成为走向灭绝的地区的主要物种。
这些寄生虫遵循不同的病程,治疗方案也不同,需要
一种用于间日疟原虫的额外药物,以消除可能导致疾病复发的肝脏阶段
感染后数年。
目前的诊断方法准确性欠佳,尤其是对间日疟原虫,
周转时间Hemex的目标是开发一种一分钟,1美元,即时诊断,
间日疟原虫的检测限比RDTs低> 5倍。该诊断平台还将具有
区分恶性疟原虫和间日疟原虫的能力,以允许适当的治疗。的
拟议的项目推进了我们目前的快速疟疾检测设备,
与显微镜相比,患者中任何疟疾寄生虫的准确率>95%。新
这种能力将被商业化,成为一个强大的,便携式的,即时护理产品。它有可能
大大减少疟疾传播,并可大大有助于减少
人类痛苦以及帮助实现消灭疟疾。
英文摘要
Project Summary/Abstract
While significant progress has been made in reducing malaria prevalence and deaths, malaria
elimination remains an extremely difficult goal. P. falciparum and P. vivax species of malaria
parasites account for ~95% of all human malaria infections. P. falciparum is more virulent and
has a higher incidence of adverse clinical outcomes, but P. vivax is more pervasive and
widespread, often becoming the predominant species in regions moving toward elimination.
These parasites follow a different course of disease and the treatment regimen differs, requiring
an additional drug for P. vivax to eliminate a liver stage which causes disease relapse potentially
years after infection.
Current diagnostics have suboptimal accuracy, especially for P. vivax, as well as delayed
turnaround times. Hemex aims to develop a one-minute, $1, point-of-care diagnostic that has a
limit of detection for P. vivax >5x lower than RDTs. This diagnostic platform will also have the
ability to differentiate between P. falciparum and P. vivax to allow for appropriate treatment. The
proposed project advances our current rapid malaria detection device, which detects the presence
of any malaria parasites in patients with >95% accuracy compared to microscopy. The new
capability will be commercialized into a robust, portable, point-of-care product. It has the potential
to greatly reduce malaria transmission and could substantially contribute towards reduction in
human suffering as well as help to achieve malaria elimination.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Using Multi-Spectral Imaging with Microchip Electrophoresis to Accurately Screen Newborns for Sickle Cell Disease
-
批准号:10255480
-
项目类别:
-
资助金额:$25.66万
-
财政年份:2021
-
负责人:PETER GALEN
-
依托单位:
Portable, affordable, quantitative microchip electrophoresis system for integrated anemia and hemoglobin variant testing
-
批准号:9909933
-
项目类别:
-
资助金额:$22.5万
-
财政年份:2020
-
负责人:PETER GALEN
-
依托单位:
Rapid, Point of Care Diagnostic for Malaria, highly sensitive for P. vivax, with species differentiation
-
批准号:10231237
-
项目类别:
-
资助金额:$82.78万
-
财政年份:2020
-
负责人:PETER GALEN
-
依托单位:
HLS-Affordable, quantitative microchip-electrophoresis for sickle cell disease screening
-
批准号:9913568
-
项目类别:
-
资助金额:$75.0万
-
财政年份:2019
-
负责人:PETER GALEN
-
依托单位:
HLS-Affordable, quantitative microchip-electrophoresis for sickle cell disease screening
-
批准号:9789452
-
项目类别:
-
资助金额:$75.0万
-
财政年份:2019
-
负责人:PETER GALEN
-
依托单位:
Affordable, quantitative, point-of-care microchip-electrophoresis for screening and treatment monitoring of sickle cell disease, thalassemias, and anemias
-
批准号:10581009
-
项目类别:
-
资助金额:$100.0万
-
财政年份:2018
-
负责人:PETER GALEN
-
依托单位:
Portable, affordable, quantitative microchip electrophoresis for hemoglobin A1C testing
-
批准号:10546889
-
项目类别:
-
资助金额:$86.54万
-
财政年份:2018
-
负责人:PETER GALEN
-
依托单位:
Portable, affordable, quantitative microchip electrophoresis for hemoglobin A1C testing
-
批准号:10656550
-
项目类别:
-
资助金额:$86.52万
-
财政年份:2018
-
负责人:PETER GALEN
-
依托单位:
ECG SOFTWARE TO DETECT ACUTE MYOCARDIAL INFARCTION
-
批准号:6215507
-
项目类别:
-
资助金额:$13.63万
-
财政年份:2000
-
负责人:PETER GALEN
-
依托单位:
海外基金